Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1977 Apr;59(4):599–601. doi: 10.1111/j.1476-5381.1977.tb07727.x

Effects of delta9-tetrahydrocannabinol and cannabidiol on a Mg2+-ATPase of synaptic vesicles prepared from rat cerebral cortex.

J C Gilbert, R G Pertwee, M G Wyllie
PMCID: PMC1667757  PMID: 139957

Abstract

1. delta9-Tetrahydrocannabinol and cannabidiol both exhibited a concentration-related inhibition of Mg2+-ATPase of vesicles prepared from synaptosomes isolated from rat cerebral cortex. Cannabidiol was about 3 times more potent than tetrahydrocannabinol. 2. These results were similar to those obtained previously using drugs with well established anticonvulsant activity. 3. Tetrahydrocannabinol at a sub-inhibitory concentration (1 micronM) increased the activity of the Mg2+-ATPase relative to values obtained with vehicle controls.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BONTING S. L., SIMON K. A., HAWKINS N. M. Studies on sodium-potassium-activated adenosine triphosphatase. I. Quantitative distribution in several tissues of the cat. Arch Biochem Biophys. 1961 Dec;95:416–423. doi: 10.1016/0003-9861(61)90170-9. [DOI] [PubMed] [Google Scholar]
  2. GRAY E. G., WHITTAKER V. P. The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat. 1962 Jan;96:79–88. [PMC free article] [PubMed] [Google Scholar]
  3. Gilbert J. C., Wyllie M. G. Effects of anticonvulsant and convulsant drugs on the ATPase activities of synaptosomes and their components. Br J Pharmacol. 1976 Jan;56(1):49–57. doi: 10.1111/j.1476-5381.1976.tb06958.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gilbert J. C., Wyllie M. G. Proceedings: Synaptic vesicle magnesium-adenosine triphosphatase as a possible site of action of anticonvulsant drugs. Br J Pharmacol. 1975 Oct;55(2):252P–252P. [PMC free article] [PubMed] [Google Scholar]
  5. Izquierdo I., Orsingher O. A., Berardi A. C. Effect of cannabidiol and of other cannabis sativa compounds on hippocampal seizure discharges. Psychopharmacologia. 1973;28(1):95–102. doi: 10.1007/BF00413961. [DOI] [PubMed] [Google Scholar]
  6. Karler R., Cely W., Turkanis S. A. The anticonvulsant activity of cannabidiol and cannabinol. Life Sci. 1973 Dec 1;13(11):1527–1531. doi: 10.1016/0024-3205(73)90141-0. [DOI] [PubMed] [Google Scholar]
  7. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  8. Whittaker V. P., Michaelson I. A., Kirkland R. J. The separation of synaptic vesicles from nerve-ending particles ('synaptosomes'). Biochem J. 1964 Feb;90(2):293–303. doi: 10.1042/bj0900293. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES